Skip to main content
. 2021 Feb 11;32(4):913–926. doi: 10.1681/ASN.2020060888

Table 1.

Patient characteristics by era (n=1,309,998)

Patient Characteristics, n Year of Initial ESKD Onset or Wait List Placement, %
1997–2000, n=217,989 2001–2004, n=244,601 2005–2008, n=270,258 2009–2012, n=284,772 2013–2016, n=292,378
Age at ESKD onset
 18–39, n=154,749 14.4 12.6 11.8 10.9 10.3
 40–49, n=214,610 17.9 17.4 16.7 15.6 14.9
 50–59, n=383,385 27.2 29.4 30.5 29.8 29.0
 60–70, n=557,254 40.5 40.6 41.0 43.8 45.8
Race/ethnicity
 Non-Hispanic White, n=603,369 46.8 45.8 45.7 46.0 46.1
 Non-Hispanic Black, n=421,801 33.5 33.4 30.0 31.2 30.4
 Asian, n=40,855 2.7 2.9 3.1 3.3 3.6
 Hispanic White, n=191,078 11.5 13.1 14.6 16.2 16.6
 Hispanic Black, n=6361 0.6 0.5 0.5 0.5 0.4
 Other, n=46,534 4.9 4.3 3.1 2.9 2.9
Sex
 Women, n=562,886 45.7 44.4 42.9 41.7 41.0
 Men, n=746,977 54.3 55.6 57.1 58.3 59.0
 Unknown, n=135 <0.1 <0.1 <0.1 <0.1 <0.1
Primary diagnosis
 Diabetes, n=642,778 48.9 49.0 48.2 48.5 50.6
 Hypertension, n=298,072 20.6 21.2 21.8 23.5 25.8
 GN, n=145,895 13.9 12.5 11.2 10.1 8.8
 Cystic disease, n=40,470 3.2 3.1 3.3 3.1 2.8
 Other/missing, n=182,783 13.4 14.1 15.5 14.8 12.0
BMI, kg/m2
 13–18, n=38,482 5.5 3.1 2.6 2.2 2.0
 19–24, n=276,845 25.5 24.3 20.8 18.5 18.1
 25–29, n=365,309 27.6 29.8 28.2 27.3 26.8
 30–34, n=265,657 16.3 19.6 20.7 21.6 22.1
 35–39, n=154,884 7.9 10.6 12.1 13.5 13.9
 40+, n=158,432 6.7 9.9 12.7 14.6 15.0
 Missing, n=50,389 10.5 2.7 2.9 2.5 2.1
ESKD network
 (S-CA) Southern California Network, n=97,068 7.0 7.5 7.2 7.5 7.7
 (N-CA) Trans-Pacific ESRD Network, n=62,034 4.7 4.6 4.7 4.8 4.9
 (WA) Northwest Renal Network, n=36,239 2.6 2.7 2.7 3.0 2.9
 (CO) Inter-Mountain ESRD Network, n=61,848 4.4 4.6 4.7 4.9 4.9
 (TX) Network of Texas, n=119,147 8.0 8.4 8.9 9.4 10.3
 (OK) ESRD Network 13, n=58,976 4.6 4.6 4.4 4.4 4.5
 (MO) ESRD Network 12, n=47,957 3.8 3.6 3.7 3.6 3.7
 (MN) Renal Network of Upper Midwest, n=81,884 6.4 6.5 6.5 6.1 5.9
 (IL) Renal Network of Illinois, n=55,605 4.4 4.3 4.3 4.2 4.0
 (IN) Tri-State R. N., n=96,347 7.3 7.3 7.4 7.5 7.3
 (MS) Network 8, n=76,491 5.7 5.6 5.9 5.9 6.0
 (FL) ESRD Network of Florida, n=76,617 5.5 5.6 5.9 6.1 6.1
 (NC) Southeastern Kidney Council, n=122,919 9.2 9.3 9.5 9.3 9.6
 (VA) Mid-Atlantic R. C., n=79,256 6.4 6.4 6.2 5.9 5.6
 (PA) ESRD Network Organization, n=56,443 4.7 4.4 4.4 4.2 3.9
 (NJ) Trans-Atlantic R. C., n=58,218 4.9 4.7 4.4 4.3 4.1
 (NY) Network of New York, n=80,726 6.9 6.5 6.1 5.8 5.7
 (CT) Network of New England, n=41,527 3.5 3.3 3.2 3.0 2.9
 Missing, n=696 0.1 0.1 <0.1 <0.1 <0.1
Comorbid conditions
 Congestive heart failure, n=335,151 26.3 25.7 26.6 25.4 24.2
 Cancer, n=60,005 3.6 4.1 5.0 5.2 4.8
 Atherosclerotic heart disease, n=212,996 20.6 20.8 16.2 14.6 10.9
 Tobacco use, n=98,508 6.6 6.5 8.0 8.2 8.0
 Hypertension, n=1,087,041 75.3 80.0 83.8 86.2 87.4
 Alcohol abuse, n=27,311 2.0 1.8 2.2 2.3 2.1
 Peripheral vascular disease, n=144,161 12.2 11.6 11.8 10.8 9.2
Median household income level, $
 <29,000, n=108,464 6.7 6.3 9.1 9.6 9.1
 29,001–36,000, n=154,661 10.0 9.9 12.1 12.8 13.5
 36,001–47,000, n=352,327 26.0 25.8 27.2 27.9 27.2
 47,001–61,000, n=335,675 27.7 28.1 24.9 24.0 24.3
 61,001–80,000, n=209,576 17.0 17.5 15.6 15.2 15.1
 >80,000, n=127,359 10.4 10.9 9.4 8.9 9.4
 Missing, n=21,936 2.2 1.7 1.7 1.5 1.4
All patients 16.6 18.7 20.6 21.7 22.3

S-CA, Southern California; N-CA, Northern California; R. N., renal network; R. C., renal coalition.